Clinical trial
A Randomized Trial of Three Regimens to Prevent Tuberculosis in HIV-Infected…
NCT00402610 · Sociedad Andaluza de Enfermedades Infecciosas, Other · Completed
Key facts
| NCT number | NCT00402610 |
|---|---|
| Title | A Randomized Trial of Three Regimens to Prevent Tuberculosis in HIV-Infected Patients With Anergy |
| Official title | A Randomized Trial of Three Regimens to Prevent Tuberculosis in HIV-Infected Patients With Anergy |
| Lead sponsor | Sociedad Andaluza de Enfermedades Infecciosas, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections, Tuberculosis |
| Intervention type | Drug |
| Interventions | isoniazid, rifampin + isoniazid, rifampin + pyrazinamide or not treatment |
| Enrollment | 332 |
| Start date | Jan 1, 1994 |
| Completion | Dec 1, 1998 |
| First posted | Nov 22, 2006 |
| Last update posted | Oct 24, 2008 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: